Circular mRNA helps cell factories make up to six times as much protein
A synthetic biology technology has been developed that converts easily degraded messenger RNA (mRNA) into a ring-shaped form inside microbial cells, increasing protein production.
The breakthrough in synthetic biology is significant because it addresses a major challenge in biomanufacturing: the instability of messenger RNA (mRNA). In traditional cell factories, mRNA is prone to degradation, which limits the amount of protein that can be produced. By converting mRNA into a circular form, researchers have effectively created a more stable template for protein synthesis. This innovation has the potential to greatly enhance the efficiency of biomanufacturing processes.
The impact of this technology is substantial, as it could enable the production of a wide range of valuable compounds, from pharmaceuticals to biofuels, using microbial cells. Currently, biomanufacturing processes often rely on complex and costly systems to stabilize mRNA, which can limit their scalability. The development of circular mRNA technology offers a more straightforward and cost-effective solution, which could democratize access to biomanufacturing and accelerate the development of new products.
As the field of synthetic biology continues to advance, it's likely that we'll see further innovations in mRNA stability and protein production. Researchers will likely explore applications of circular mRNA technology in various industries, including biotechnology, pharmaceuticals, and agriculture. To watch next: expect updates on the scalability and commercialization of this technology, as well as its potential integration with other synthetic biology tools to create even more efficient cell factories.
Originally reported by phys.org. StudentNews adds analysis for science & discovery readers.